Glass Enamel & Ophtalmic Optics, Volume. 50, Issue 1, 22(2022)
The Analysis of Clinical Trial of Slowing the Progression of Myopia in Children with Low Red Laser
The purpose of this study was to quantify the effectiveness of low-lever red laser (LLRDL) in slowing the progression of myopia axial length elongation. Myopic children aged 8 to 12 years were enrolled in a year (with follow-ups at 3 month and 6 month), single-masked, randomized clinical trial. Subjects in each group were randomized to either a LLRDL (test) group or single vision spectacles (control) group. This study was to assess the changing values from 3 and 6 month follow-ups from the baseline, especially the axial length. After 3 months and 6 months, 82.5% and 72.7% of myopic eyes of the subjects enrolled had no axial elongation compared with baseline, while the control group had 100% axial elongation, and there were significant differences between red light treatment group and control group (p<0.000 1). LLRDL had significant efficacy in control axial elongation. But there were no significant difference between chamber depth, cornea power or choroidal thickness.
Get Citation
Copy Citation Text
ZHOU Lei, QIU Kaikai, TONG Liyang. The Analysis of Clinical Trial of Slowing the Progression of Myopia in Children with Low Red Laser[J]. Glass Enamel & Ophtalmic Optics, 2022, 50(1): 22
Category:
Received: Dec. 22, 2021
Accepted: --
Published Online: Jan. 10, 2023
The Author Email: